EXECUTIVE SUMMARY

The report titled India Diabetes Industry Research and Forecasts to FY2016 Shift towards Modern Insulin Delivery Devices provides a comprehensive analysis on the market size of diabetes industry on the basis of number of diabetic patients in India, sales of anti-diabetic drugs and diabetes devices in India, market segmentation by Type 1 and Type 2 diabetic patients, Insulin and oral anti-diabetic drug market in India. The report also entails the size of diabetes testing devices and insulin delivery devices segments further categorized into test strips, glucose meters, lancets, vial and syringes, reusable insulin pens and prefilled pens. The report also covers competitive landscape and profiles of major players operating in the diabetes industry.
India is the second largest diabetes-affected nation in the world after China (~ million), accounting for ~ million diabetic patients followed by the US (~ million) in 2011. India contributed maximum to regional mortality with ~ deaths caused due to diabetes in 2011. The most affected diabetic patients falls in the age group of 40-59 years which accounts about ~% of total diabetic population and the least affected age group is 20-39 accounting ~% of total diabetic patients in India. Despite a high prevalence rate of diabetes, the country spends merely about USD ~ million which is just 1% of the total diabetes spending worldwide.
Indian anti-diabetic drugs market contributed around ~% of total global anti-diabetic drugs market. In FY2008, the value of anti-diabetic drugs market in India was USD ~ million which grew up to USD ~ million in FY2011. The most popular oral anti-diabetic drugs are biguanides, gliclazide, gliclazide with metformine, rosiglitazone and Pioglitazone of which biguanides contributed around ~% market share.
The Indian diabetes market is fragmented with the presence of several players such as Novo Nordisk, Eli Lilly, Sanofi-Aventis, Biocon, Wockhardt, Shreya Lifescience, GlaxoSmithKline, Panacea Biotech, Strides Acrolab, Torrent Pharmaceuticals, Ranbaxy, Dr. Reddys, Cipla and Sun Pharmaceuticals.
Novo-Nordisk is the market leader in the Insulin market with the share of ~% followed by Eli Lilly with market share of ~% in 2011. While in oral diabetic market, USV India is the market leader with ~% market share followed by Sun Pharma and Novo-Nordisk with market share of ~% and ~% respectively
The insulin market is estimated to reach USD ~ million (INR ~ crore) by FY2016 with a share contribution of around ~% in total anti-diabetic drugs market in India.
The diabetes testing device segment dominated the Indian diabetic device market in FY2011 with the market share of ~%. Vial and syringes has traditionally dominated the insulin delivery devices market however with the introduction of modern insulin delivery devices, the market share of traditional devices is deteriorating. The reusable modern insulin delivery devices are seemingly becoming the widely used injectables in India.
Insulin delivery device segment will continue to register growth with the advances in non-intrusive insulin delivery methods. With the increasing pervasiveness of diabetes in India, the country will witness a slew of insulin pens and pumps in the coming years. There are atleast ~ brands of insulin pens which are currently available in the market. It is estimated that the diabetes device market will increase to USD ~ million (INR ~ crore) by FY2015 at a CAGR of ~%.
Key Topics Covered in the Report:
The market size of the India diabetes market on the basis of number of type 1 and type 2 diabetes patients, FY2005-FY2011
The Indian anti-diabetic drug and diabetes device market size on the basis of revenue, FY2005-FY2011
Market segmentation of anti-diabetes drugs market into Insulin and Oral anti-diabetic drug sales and diabetes devices into testing (test strips, lancets and meters) and delivery devices (vial and syringes, reusable insulin pens, prefilled insulin pens), FY2005-FY2011
Trends and developments in the Indian Anti-diabetic drug and Device Care market
Competitive landscape of the Insulin, Oral anti-diabetic drug, diabetes testing and delivery devices segment in India, FY2011
Future outlook and projections of Indian anti-diabetic drugs and diabetes device market on the basis of sales, FY2012-FY2016
Macroeconomic and industry factors including number of diabetes patients in India, personal disposable income, Indian Pharmaceutical market revenue and R&D expenditure and health expenditure, FY2005-FY2016

TABLE OF CONTENTS
1. India Diabetes Market Introduction
2. India Diabetes Market Size, FY2005-FY2011
2.1. By Number of Diabetes Patients, FY2005-FY2011
3. India Diabetes Market Segmentation, FY2005-FY2011
3.1. By Type 1 And Type 2 Diabetes Patients, FY2005-FY2011
4. India Anti-Diabetic Drug Market Introduction
4.1. India Anti-Diabetic Drug Market Size by Value, FY2005-FY2011
4.2. India Anti-Diabetic Drugs Market Segmentation, FY2005-FY2011
4.2.1. By Insulin and Oral Anti- Diabetic Drugs, FY2005-FY2011
4.3. India Anti-Diabetic Drug Market Trends and Developments
Shifting Preference towards Insulin from oral anti-diabetic drugs
Mounting Proportion of Undiagnosed Diabetes Patients
Rising Distribution and Marketing Alliances
4.4. India Anti-Diabetic Drug Market Competitive Landscape, FY2005-FY2011
4.4.1. Market Share of Major Players in Insulin Market, FY2005-FY2011
4.4.2. Market Share of Major Players in Oral Anti-Diabetic Drugs, FY2011
4.5. India Anti-Diabetic Drug Market Future Outlook
4.5.1. Cause and Effect Relationship Between Dependent and Independent Factors in the India Anti-Diabetic Drug Market
4.5.2. India Anti-Diabetic Drug Market Future Projections, FY2012-FY2016
4.5.3. Insulin and Oral Anti- Diabetic Drug Market Future Projections, FY2012-FY2016
4.6. Company Profiles of Major Players in Insulin Market
4.6.1. Novo-Nordisk India
Company Overview
Business Strategies
Financial Performance
4.6.2. Eli Lilly
Company Overview
Business Strategies
Financial performance
4.6.3. Sanofi-Aventis
Company Overview
Business Strategies
Financial Performance
4.7. Company Profiles of Major Players in the Indian Oral Anti-Diabetic Drug Market, FY2011
5. India Diabetes Device Market Introduction
5.1. India Diabetes Device Market Size by Value, FY2005-FY2011
5.2. India Diabetes Device Market Segmentation, FY2005-FY2011
5.2.1. By Diabetic Testing and Delivery Devices, FY2011
5.3. India Diabetes Device Market Trends and Developments
Rising Usage of Modern Insulin Delivery Devices
Advancement in Technology
5.4. Competitive Landscape of Major Players in the India diabetes Testing Device Market, FY2011
5.5. India Diabetes Device Market Future Outlook
5.5.1. Cause and Effect Relationship Between Dependent and Independent Factors in the India Diabetes Device Market
5.5.2. India Diabetes Device Market Future Projections, FY2012-FY2015
6. Macro-Economic and Industry Factors: Current And Projections
6.1. Number of Diabetic Patients in India, FY2005-FY2016
6.2. India Pharmaceutical Industry Sales, 2005-2016
6.3. India Pharmaceutical Reasearch and Development Expenditure, 2005-2016
6.4. Health Expenditure in India, 2005-2016
6.5. Personal Disposable Income of India, 2005-2016
7. Market Definition
8. Abbreviations
9. Appendix
9.1. Research Methodologies
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
9.2. Disclaimer

List of Tables

NA

List of Figures

NA